http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006217783-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b503783ce1da914a3bba482681c7fff
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0651
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0663
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-326
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36046
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-08
filingDate 2005-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10f8ddcb21cdbe49bfc35cffdef64159
publicationDate 2006-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2006217783-A1
titleOfInvention Treatment of vision disorders using electrical, light, and/or sound energy
abstract A non-invasive ocular therapy for vision disorders is provided. First and second electrodes of a direct current source are electrically contacted so as to deliver current to and/or about an area proximal one or more eyes of a subject. A direct electrical current of between about 1-800 microamps, at a resistance assumption of about 500 ohms, is generated between the electrodes for a preselected duration. Preferably, the direct electrical current is generated at a select frequency profile as a function of time, and with a carrier signal of about 10,000-12,000 hertz. Advantageously, the subject therapy is augmented via application of light energy to the eye(s), as well as by the application of infrasonic sound waves directly into eyes.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2111250-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008262575-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2111250-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8209024-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005209656-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11191478-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014187998-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109069831-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014005514-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8655452-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9801758-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008091559-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9079023-B2
priorityDate 2004-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4614193-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5935155-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005004625-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6275735-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004176820-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6154671-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5944747-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6306075-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005137649-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6035236-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004106965-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6101411-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6990377-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003233137-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395300
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5957
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449433766
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400026
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6093231

Total number of triples: 51.